Sun Pharma to introduce its version of Vortioxetine in India under an exclusive patent license from Lundbeck
Sun Pharmaceutical Industries Limited today announced that one of its wholly-owned subsidiaries has entered into an exclusive patent licensing agreement with H. Lundbeck A/S (“Lundbeck”) to market and distribute its … Read More










